Cambridge Investment Research Advisors’s Mandiant, Inc. Common Stock MNDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,672
Closed -$451K 3195
2022
Q2
$451K Sell
20,672
-1,245
-6% -$27.3K ﹤0.01% 2036
2022
Q1
$489K Sell
21,917
-10,520
-32% -$195K ﹤0.01% 2112
2021
Q4
$569K Sell
32,437
-455
-1% -$7.99K ﹤0.01% 1998
2021
Q3
$585K Buy
32,892
+4,630
+16% +$87.8K ﹤0.01% 1925
2021
Q2
$571K Sell
28,262
-26,634
-49% -$546K ﹤0.01% 1944
2021
Q1
$1.07M Buy
54,896
+19,198
+54% +$401K 0.01% 1393
2020
Q4
$823K Sell
35,698
-1,165
-3% -$17.9K ﹤0.01% 1431
2020
Q3
$455K Buy
36,863
+10,108
+38% +$138K ﹤0.01% 1663
2020
Q2
$326K Buy
26,755
+3,348
+14% +$38.8K ﹤0.01% 1829
2020
Q1
$248K Buy
23,407
+146
+0.6% +$2.1K ﹤0.01% 1790
2019
Q4
$385K Buy
23,261
+2,366
+11% +$38K ﹤0.01% 1757
2019
Q3
$279K Buy
20,895
+27
+0.1% +$383 ﹤0.01% 1878
2019
Q2
$309K Sell
20,868
-2,092
-9% -$32.1K ﹤0.01% 1734
2019
Q1
$385K Sell
22,960
-923
-4% -$15.5K ﹤0.01% 1652
2018
Q4
$387K Sell
23,883
-7,488
-24% -$134K ﹤0.01% 1478
2018
Q3
$533K Buy
31,371
+784
+3% +$12.5K 0.01% 1406
2018
Q2
$471K Buy
30,587
+785
+3% +$13.6K 0.01% 1430
2018
Q1
$505K Sell
29,802
-6,113
-17% -$98.5K 0.01% 1352
2017
Q4
$510K Buy
35,915
+2,585
+8% +$39.3K 0.01% 1313
2017
Q3
$559K Buy
33,330
+5,150
+18% +$79.1K 0.01% 1193
2017
Q2
$429K Buy
28,180
+12,250
+77% +$174K 0.01% 1288
2017
Q1
$201K Buy
15,930
+959
+6% +$11.4K ﹤0.01% 1612
2016
Q4
$178K Buy
+14,971
New +$194K ﹤0.01% 1522
2016
Q3
Sell
-10,357
Closed -$171K 1800
2016
Q2
$171K Buy
+10,357
New +$167K ﹤0.01% 1410
2016
Q1
Sell
-10,135
Closed -$210K 1671
2015
Q4
$210K Buy
10,135
+1,840
+22% +$46.1K 0.01% 1343
2015
Q3
$264K Buy
+8,295
New +$346K 0.01% 1092

Other funds holding MNDT

Cambridge Investment Research Advisors's MNDT Position: Q3 2022 in Review

Cambridge Investment Research Advisors sold out of Mandiant, Inc. Common Stock (MNDT) in Q3 2022, closing a stake of 20,672 shares — an estimated $451K sold.

Cambridge Investment Research Advisors first reported a position in MNDT in Q3 2015 and held it in 26 quarters. The position peaked at $1.07M in Q1 2021. 3 funds tracked by Wall St. Rank hold MNDT as of Q3 2022.

  • Cambridge Investment Research Advisors reported no remaining Mandiant, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 20,672 Mandiant, Inc. Common Stock shares in Q3 2022, an estimated $451K.
  • Cambridge Investment Research Advisors first reported a position in Mandiant, Inc. Common Stock in Q3 2015 and held it in 26 quarters.
  • Cambridge Investment Research Advisors's Mandiant, Inc. Common Stock position peaked at $1.07M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q3 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.